Nonclinical Pharmacokinetics and Activity of Etirinotecan Pegol (NKTR-102), a Long-Acting Topoisomerase 1 Inhibitor, in Multiple Cancer Models
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2577-7
Full Text
Open PDFAbstract
Available in full text
Date
September 17, 2014
Authors
Publisher
Springer Science and Business Media LLC